Cagrilintide is a long-acting amylin analog with a fatty acid side chain. With the molecular formula C₁₉₀H₂₉₇N₅₁O₅₈ and a molecular weight of 4220.8 g/mol (CAS: 1417329-69-3), it structurally mimics endogenous peptides while extending its sequence.
Long-acting amylin analogueAlhalabi et al. (2026) investigated Cagrilintide's binding affinity and receptor interactions in vitro (PMID: 41702251).
PMID: 41702251Briere et al. (2025) investigated Cagrilintide's binding affinity and receptor interactions in vitro (PMID: 41109426).
PMID: 41109426Published research demonstrates Cagrilintide modulates targeted signaling cascades within cell tissue models (PMID: 41702251).
In cellular environments, Cagrilintide exhibits selective binding and corresponding pathway activation (PMID: 41109426).
All compounds are sold strictly for laboratory research use. Not for human or animal consumption. These products are not drugs, supplements, or food. Statements have not been evaluated by the FDA. Must be 21+ to purchase. This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.
